Your browser doesn't support javascript.
loading
Midkine in inflammation.
Weckbach, Ludwig T; Muramatsu, Takashi; Walzog, Barbara.
Affiliation
  • Weckbach LT; Institute of Cardiovascular Physiology and Pathophysiology, Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians-Universität, 80336 Munich, Germany.
ScientificWorldJournal ; 11: 2491-505, 2011.
Article in En | MEDLINE | ID: mdl-22235180
The 13 kDa heparin-binding growth factor midkine (MK) was originally identified as a molecule involved in the orchestration of embryonic development. Recent studies provided evidence for a new role of MK in acute and chronic inflammatory processes. Accordingly, several inflammatory diseases including nephritis, arthritis, atherosclerosis, colitis, and autoimmune encephalitis have been shown to be alleviated in the absence of MK in animal models. Reduced leukocyte recruitment to the sites of inflammation was found to be one important mechanism attenuating chronic inflammation when MK was absent. Furthermore, MK was found to modulate expression of proinflammatory cytokines and the expansion of regulatory T-cells. Here, we review the current understanding of the role of MK in different inflammatory disorders and summarize the knowledge of MK biology.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Cytokines / Inflammation / Nerve Growth Factors Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: ScientificWorldJournal Journal subject: MEDICINA Year: 2011 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Main subject: Cytokines / Inflammation / Nerve Growth Factors Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: ScientificWorldJournal Journal subject: MEDICINA Year: 2011 Type: Article Affiliation country: Germany